BVMed leaflet on apheresis:
This article was originally published in Clinica
Executive Summary
The benefits of therapeutic apheresis are described in a new brochure from BVMed, the German industry association for medical devices. The 32-page document describes apheresis as an innovative, extra-corporeal blood filtration procedure for eliminating certain toxins with very few side effects. "Therapeutic apheresis offers many medical disciplines the ability to provide a non-traumatic therapy which can be optimally adapted to the treatment of the individual," says BVMed. The association agreed to represent companies in the area of therapeutic apheresis in November last year (see Clinica No 943, p 6).
You may also be interested in...
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.